RU2010134123A - PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES - Google Patents
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES Download PDFInfo
- Publication number
- RU2010134123A RU2010134123A RU2010134123/15A RU2010134123A RU2010134123A RU 2010134123 A RU2010134123 A RU 2010134123A RU 2010134123/15 A RU2010134123/15 A RU 2010134123/15A RU 2010134123 A RU2010134123 A RU 2010134123A RU 2010134123 A RU2010134123 A RU 2010134123A
- Authority
- RU
- Russia
- Prior art keywords
- pharmaceutical composition
- composition according
- fexofenadine
- amount
- filler
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1. Фармацевтическая композиция для лечения аллергических заболеваний, включающая в качестве действующего вещества терапевтически эффективное количество фексофенадина и вспомогательные вещества - наполнитель, дезинтегрант и соль стеариновой кислоты, отличающаяся тем, что содержит дополнительно гидроксипропилцеллюлозу, глидант и солюбилизатор. ! 2. Фармацевтическая композиция по п.1, отличающаяся тем, что содержит фексофенадин в виде гидрохлорида. ! 3. Фармацевтическая композиция по п.2, отличающаяся тем, что содержит гидроксипропилцеллюлозу в количестве 0,005-0,15 мас.ч на 1 мас.ч. действующего вещества. ! 4. Фармацевтическая композиция по п.3, отличающаяся тем, что содержит в качестве наполнителя комбинацию лактозы и крахмала. ! 5. Фармацевтическая композиция по п.4, отличающаяся тем, что содержит лактозу в виде моногидрата и крахмал в виде прежелатинизированного крахмала. ! 6. Фармацевтическая композиция по п.5, отличающаяся тем, что содержит ингредиенты при следующем соотношении, мас.ч. на 1 мас.ч. действующего вещества: !Гидроксипропилцеллюлоза 0,008-0,12 Наполнитель 0,2-1,4 Дезинтегрант 0,03-0,2 Глидант 0,006-0,2 Солюбилизатор 0,002-0,05 ! 7. Фармацевтическая композиция по п.6, отличающаяся тем, что она выполнена в виде таблетки. ! 8. Фармацевтическая композиция по п.7, отличающаяся тем, что она содержит фексофенадин в количестве 0,12 г ± 5%. ! 9. Фармацевтическая композиция по п.7, отличающаяся тем, что она содержит фексофенадин в количестве 0,18 г ± 5%. ! 10. Фармацевтическая композиция по п.8 или 9, отличающаяся тем, что она выполнена в виде таблетки, покрытой оболочкой. 1. A pharmaceutical composition for the treatment of allergic diseases, comprising as the active substance a therapeutically effective amount of fexofenadine and excipients - a filler, a disintegrant and a stearic acid salt, characterized in that it additionally contains hydroxypropyl cellulose, glidant and a solubilizer. ! 2. The pharmaceutical composition according to claim 1, characterized in that it contains fexofenadine in the form of a hydrochloride. ! 3. The pharmaceutical composition according to claim 2, characterized in that it contains hydroxypropyl cellulose in an amount of 0.005-0.15 wt.h per 1 wt.h. active substance. ! 4. The pharmaceutical composition according to claim 3, characterized in that it contains as a filler a combination of lactose and starch. ! 5. The pharmaceutical composition according to claim 4, characterized in that it contains lactose in the form of monohydrate and starch in the form of pregelatinized starch. ! 6. The pharmaceutical composition according to claim 5, characterized in that it contains ingredients in the following ratio, parts by weight per 1 part by weight active substance:! Hydroxypropyl cellulose 0.008-0.12 Filler 0.2-1.4 Disintegrant 0.03-0.2 Glidant 0.006-0.2 Solubilizer 0.002-0.05! 7. The pharmaceutical composition according to claim 6, characterized in that it is made in the form of a tablet. ! 8. The pharmaceutical composition according to claim 7, characterized in that it contains fexofenadine in an amount of 0.12 g ± 5%. ! 9. The pharmaceutical composition according to claim 7, characterized in that it contains fexofenadine in an amount of 0.18 g ± 5%. ! 10. The pharmaceutical composition according to claim 8 or 9, characterized in that it is made in the form of a coated tablet.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010134123/15A RU2453315C2 (en) | 2010-08-17 | 2010-08-17 | Pharmaceutical composition for allergic diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2010134123/15A RU2453315C2 (en) | 2010-08-17 | 2010-08-17 | Pharmaceutical composition for allergic diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2010134123A true RU2010134123A (en) | 2012-02-27 |
RU2453315C2 RU2453315C2 (en) | 2012-06-20 |
Family
ID=45851586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2010134123/15A RU2453315C2 (en) | 2010-08-17 | 2010-08-17 | Pharmaceutical composition for allergic diseases |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2453315C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180109991A (en) * | 2016-02-19 | 2018-10-08 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | A pharmaceutical composition containing an imidazoline derivative |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1003528B1 (en) * | 1997-08-14 | 2002-09-25 | Aventis Pharmaceuticals Inc. | Method of enhancing bioavailability of fexofenadine and its derivatives |
US20050065183A1 (en) * | 2003-07-31 | 2005-03-24 | Indranil Nandi | Fexofenadine composition and process for preparing |
RU2283649C1 (en) * | 2005-10-27 | 2006-09-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Pharmaceutical composition for allergic disorder treatment |
-
2010
- 2010-08-17 RU RU2010134123/15A patent/RU2453315C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2453315C2 (en) | 2012-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501421A1 (en) | Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n`-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine | |
UA109421C2 (en) | PHARMACEUTICAL COMPOSITION CONTAINING SIGMA-RECEPTOR LIGANDS | |
RU2013153140A (en) | A NEW ASSOCIATION BETWEEN 4- {3- [CIS-HEXAHYDROCYCLOPENT [C] PYRROL-2 (1H) - IL] PROPOXY} BENZAMIDE AND ACETYLCHOLINESTERESIS INHIBITOR AND PHARMACEZERETIC CEREIS | |
RU2010134123A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ALLERGIC DISEASES | |
RU2008115582A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PARKINSON'S DISEASE | |
RU2013124416A (en) | DIINDOLYLMETHANE MEDICINAL PRODUCT AND ITS APPLICATION FOR TREATMENT OF INFLUENZA AND RESPIRATORY VIRAL INFECTIONS | |
RU2013120455A (en) | COMBINED DRUG FOR TREATMENT OF FUNGAL NAIL DISEASES | |
RU2012145513A (en) | METHOD FOR PRODUCING INTEGRATED PRODUCT WITH IMMUNOMETABOLIC AND ANTHELMINTIC ACTIVITY | |
RU2017112352A (en) | SOLID MEDICINAL FORM INDOL-3-CARBINOL | |
RU2013157797A (en) | PHARMACEUTICAL COMPOSITION FOR TREATING SUGAR DIABETES | |
RU2010131342A (en) | PHARMACEUTICAL COMPOSITION (OPTIONS) FOR PREVENTION AND TREATMENT OF DISEASES OF THE NERVOUS SYSTEM AND METHOD OF ITS PRODUCTION | |
RU2010149497A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFECTIOUS INFLAMMATORY DISEASES IN GYNECOLOGY AND METHOD FOR PRODUCING IT | |
RU2011104563A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ARTERIAL HYPERTENSION AND CONSTANT HEART FAILURE AND METHOD FOR ITS PRODUCTION | |
RU2013121820A (en) | COMBINED MEDICINE FOR THE ELIMINATION OF SYMPTOMS AND TREATMENT OF ACUTE RESPIRATORY VIRAL INFECTIONS AND INFLUENZA | |
RU2008145723A (en) | DRUG ACTIVITY MEDICINAL PRODUCT | |
RU2012105183A (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTION OF THE MITOMYCIN-O PROLIFERATIVE CELL REACTION | |
RU2011109432A (en) | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF A HEART OF A LONG-TERM ACTION | |
RU2009142700A (en) | ANTI-INFLAMMATORY AND ANTI-ALLERGIC MEDICINE AND PHARMACEUTICAL COMPOSITION ON ITS BASIS | |
RU2011114008A (en) | PHARMACEUTICAL ANTI-DIABETIC COMPOSITION AND METHOD FOR PRODUCING AN ANTI-DIABETIC COMPOSITION | |
RU2009134910A (en) | COMBINED ANTI-TUBERCULOSIS PHARMACEUTICAL COMPOSITION | |
RU2012121055A (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DISEASES ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION | |
RU2012153668A (en) | COMBINED MEDICINE FOR THE TREATMENT OF ARTERIAL HYPERTENSION IN PATIENTS WITH DIABETES MELLITUS | |
RU2017144206A (en) | The use of the pharmaceutical composition based on the magnesium salt of aminoethanesulfonic acid with hepatoprotective activity for the prevention and treatment of hepatitis | |
RU2016146645A (en) | PHARMACEUTICAL COMPOSITION OF 1-HYDROXY-4-CYCLOHEXYLAMINOADAMANTANE HYDROCHLORIDE AND SODIUM OF 4-HYDROXYXOXYLIC ACID, IMPROVING MENTAL AND PHYSICAL PERFORMANCE | |
RU2008139377A (en) | SOLID DOSED MEDICINAL FOR TREATMENT OF DIABETES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20180818 |